PP-F11N lutetium Lu-177

Star0

DB17503InvestigationalSmall molecule

PP-F11N lutetium Lu-177: Overview.

Mechanism: Pharmacologically active on Gastrin/cholecystokinin type B receptor
Curator reviewed
Formula / weight: C₉₀H₁₂₀LuN₁₉O₃₅ · 2204.992 g/mol (avg)
Also known as: Lutetium lu 177 pp-f11n
Code names: 177LU-DOTA-(D-GLU) 6-ALA-TYR-GLY-TRP-NLE-ASP-PHENH2 · (177LU)PP-F11N · PP-F11N(177LU)

Resolves to

Compound

UNII639NVQ0SXFCAS1771736-69-6

Structure

InChIKeyDTEPIUGEQLNRHF-XMGMVKEQSA-KSMILES

[177Lu+3].CCCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CNC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O

Targets

P32239CCKBR

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with PP-F11N lutetium Lu-177, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account